Baby Safety / Compounds / Metonitazene

Is Metonitazene safe for babies and kids?

Severe risk for kids

Infants are more vulnerable to Metonitazene than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is metonitazene?

The IUPAC name is 2-ethyl-2,3-dimethyl-3,4-dihydro-1H-quinolin-7-ol.

Also known as: 14680-51-4, A7FF4K4CWB, DEA NO. 9757, DTXSID901336445.

IUPAC name
2-ethyl-2,3-dimethyl-3,4-dihydro-1H-quinolin-7-ol
CAS number
14680-51-4
Molecular formula
C13H19NO
Molecular weight
205.3 g/mol
SMILES
CCN(CC)CCn1c(/N=N/c2ccc(OC)cc2)c(-c2ccccc2)c2ccccc21
PubChem CID
117193907

Risk for babies

Severe risk

Infants are more vulnerable to Metonitazene than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Metonitazene, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified Metonitazene.

AgencyYearClassificationNotes
DEA2022Schedule I controlled substance (emergency scheduling)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter metonitazene

  • Illicit Drug
  • Research Chemical

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Metonitazene:

  • Buprenorphine/naloxone (for OUD treatment)
    Trade-offs: Same as isotonitazene entry — partial agonist with ceiling effect.
    Relative cost: Covered by insurance/Medicaid

Frequently asked questions

Is metonitazene safe for kids?

Infants are more vulnerable to Metonitazene than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What should I do if my child is exposed to metonitazene?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Metonitazene in the baby app

Look up products containing metonitazene, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. —

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →